← feed

Is NCT03185143 results overdue?

Yes — results are overdue. Primary completion was 2018-05-07; the FDAAA-801 reporting deadline (2019-05-07) passed 2648 days ago and no results are posted on ClinicalTrials.gov.

Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea

NCT IDNCT03185143 ↗
SponsorAllodynic Therapeutics, Inc (INDUSTRY)
PhasePHASE2, PHASE3
StatusCOMPLETED
Primary completion2018-05-07 (ACTUAL)
Reporting deadline2019-05-07 (completion + 365d)
Days overdue2648
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 a8acc86695cb9dfc… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03185143. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →